Robert Borzio
Adult Reconstructive Orthopaedic Surgery · Red Bank, NJNPI 1255699302
Payments from drug & device makers
What this record shows
This record is dominated by education: $7,500 of the $8,341 with a category attached, or 89.9%. Smith+Nephew accounts for 99.7% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $8,178 and has fallen 99.8% since, to $14 in 2025.
Across 11 payments — averaging $758.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$8K
- Sanofi-aventis U.S. LLC$15
- Stryker$14
What the payments were for
- Food & beverage$84110%
- Education$7,50090%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 9 | $8,312 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Stryker | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,341 in reported general payments places this provider in the 55th percentile of 39 adult reconstructive orthopaedic surgery providers in New Jersey.
See all adult reconstructive orthopaedic surgery providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 136 | $2,800 |
| Meloxicam | 246 | $598 |
| Oxycodone Hcl | 68 | $546 |
| Tramadol Hcl | 176 | $537 |
| Naproxen | 91 | $348 |
| Cefadroxil | 55 | $332 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 32 | $218 |
| Amoxicillin | 135 | $169 |
| Methylprednisolone | 15 | $69 |
| Clindamycin Hcl | 26 | $47 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Red Bank
- Atul KamathManasquan$4M
- Alfred TriaSomerset$582K
- John DundonHackettstown$573K
- Ismar DizdarevicRidgewood$368K
- David FeldmanEnglewood$335K
- Mark PizzurroRidgewood$239K
- Jeffrey LearyNew Providence$148K
- Timothy HendersonWayne$140K
- Anthony CostaEatontown$95K
- Gregory RoehrigManasquan$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.